Last update 07 Jun 2025

Lu-AE-04621

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
LU AE 04621, LU AE04621
Target
DRDs
Action
agonists
Mechanism
DRDs agonists(Dopamine receptors agonists)
Therapeutic Areas
Nervous System DiseasesEndocrinology and Metabolic Disease
Active Indication-
Inactive Indication
Parkinson Disease
Originator Organization
H. Lundbeck A/SH. Lundbeck A/S
Active Organization-
Inactive Organization
H. Lundbeck A/SH. Lundbeck A/S
License Organization-
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Lu-AE-04621
NCT02649608
/ CompletedPhase 1
Interventional, Open-label, Exploratory Study Investigating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Lu AE04621 and the Active Metabolite Lu AA40326 After Ascending Oral Doses of Lu AE04621 to Patients With Parkinson's Disease
100 Clinical Results associated with Lu-AE-04621
Login to view more data
100 Translational Medicine associated with Lu-AE-04621
Login to view more data
100 Patents (Medical) associated with Lu-AE-04621
Login to view more data
100 Deals associated with Lu-AE-04621
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Parkinson DiseasePhase 1
United States
H. Lundbeck A/SH. Lundbeck A/S
01 Jan 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT02649608 (CTgov)
Phase 1
Parkinson Disease
15
(0.04 mg Lu AE04621)
otykzuaomm = tojujfldtz kwqhxhitic (ywvuvejsde, lmjxcnhzwx - oiqvrdwqeu)
View more
-
02 Dec 2019
(0.08 mg Lu AE04621)
otykzuaomm = ulyxzenrxm kwqhxhitic (ywvuvejsde, rzyapbvigd - dmiajrnwvq)
View more
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free